We believe industry focus is an important component of our strategy, and a core strength to the management teams and discerning investors with whom we collaborate.
Whether a disruptive, early-to-late-stage company; niche venture fund; or innovative, lower middle-market business, the primary verticals include:
- MedTech: Novel Medical Devices (Respiratory, Cardiovascular, and Neurological) and 3D Bioprinting
- BioTech: Precision Medicine, Infectious Disease Diagnosis/Treatment, Ocular Disease, and Genome Editing
- NanoTech: Aerospace, Optics, Energy, Diagnostics, and Water
- Frontier Tech: Blockchain, Applied Artificial Intelligence & Machine Learning, Robotics, IoT/IIoT, AR/VR, and Automation
- Digital Health: Diagnostics and Therapeutics
- Sustainability and Impact
Strategic Advisory Board
The Strategic Advisory Board (SAB) compliments the ongoing activities of 10 || 2 Capital Partners, LLC and select clients. Comprised of influential senior executives and leading professionals, the SAB provides a rich source of industry contacts, operating experience and strategic insight in the focused industry verticals.